News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Oman proposed joint regional management of the Strait of Hormuz using voluntary transit fees, a diplomatic move that could lower shipping risk if accepted.
  • Analysts upgraded Verizon, citing a 6.3% yield, robust free cash flow and AI-driven fiber revenue that could support a stock re-rating.
  • Univest pitched as a tactical swing buy on net interest income tailwinds and conservative credentials, implying short-term upside for regional bank shares.
  • TOP Ships agreed to sell an SPV tied to a newbuilding MR tanker for about $6.5 million, with closing expected by September 30, 2026.
  • Leonardo DRS agreed to buy Raft for $450 million to bolster multi-domain AI and data fusion capabilities, expected accretive to earnings.

Latest Articles

Topicus Poised for a Tactical Recovery: Buy the Turn

Topicus Poised for a Tactical Recovery: Buy the Turn

Topicus has been punished by investor impatience after a string of integration and growth hiccups. We view the current setup as a tactical long: the business still owns durable vertical SaaS assets, free-cash-generation potential and visible margin leverage. This trade pairs a disciplined entry with a tight stop and a clear target to capture a mult…

GDEV announces results for the first quarter of 2026

GDEV announces results for the first quarter of 2026

GDEV Inc. reported a 2% year-over-year revenue increase to $99 million in Q1 2026, led by increased in-app purchases. Profit after tax rose 22% to $17 million, with adjusted EBITDA up 15% to $18 million. Selling and marketing expenses declined 13%, reflecting more efficient user acquisition strategies. The company's mobile segment grew while PC boo…

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Director Bienaime's Stock Purchase at Immunome Signals Internal Confidence Amid Drug Development Milestones

Immunome director Jean Jacques Bienaime recently acquired a substantial block of the company's common stock, signaling internal confidence. This activity is coupled with positive developments regarding Immunome's drug candidate, varegacestat. The company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for treatin…

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

AIM ImmunoTech Inc. announced a significant improvement in its stockholder equity, moving from a deficit of $9.8 million at the end of 2025 to a positive $2.1 million by March 31, 2026. Additionally, the company extended the maturity date of its promissory note with Streeterville Capital to June 2027, enhancing financial flexibility. These developm…

Most Economists See No Fed Rate Cut This Year as Energy-Driven Inflation Persists

Most Economists See No Fed Rate Cut This Year as Energy-Driven Inflation Persists

A survey of economists conducted May 14-19 shows a majority now expect the Federal Reserve to keep its policy rate unchanged through much of the year, deferring previously widely-anticipated cuts into next year. The shift follows an energy-led surge in inflation since the start of the war in Iran, which most forecasters still regard as transitory e…

JPMorgan Executive: AI Has Shifted From Hype to Scaled Execution

JPMorgan Executive: AI Has Shifted From Hype to Scaled Execution

Kevin Brunner, JPMorgan Chase & Co.’s global chair of investment banking and mergers and acquisitions, said artificial intelligence has moved beyond speculative hype into practical implementation and scaling. Speaking at the bank’s global technology, media and communications conference in Boston, Brunner described AI as a driving factor in how corp…

Webull Readies Vega Analyst, an AI Tool for Customized Stock Reports

Webull Readies Vega Analyst, an AI Tool for Customized Stock Reports

Webull is preparing to unveil Vega Analyst, an artificial intelligence-driven research feature that produces bespoke stock reports based on user-selected research modules. Integrated into the existing Vega suite, the tool will deliver real-time analyses using current market data and will be offered as a paid monthly add-on with a limited free optio…

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

Artiva Biotherapeutics has appointed veteran biotech executive Diego Miralles, M.D., as President and Head of Research and Development. Dr. Miralles brings extensive experience in advancing therapeutics from discovery through FDA approval and commercialization. This strategic leadership addition coincides with Artiva's plans to initiate a Phase 3 r…

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Lifeward Ltd. announced the promotion of Dr. Keith D. Rose to Chief Medical Officer, highlighting his 30 years of expertise in rehabilitation medicine and neuroscience. This leadership change aligns with Lifeward's strategic focus on expanding its neurorehabilitation product portfolio and advancing its biomedical platforms, including therapies targ…

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

Onconetix, Inc., a biotechnology company specializing in oncology solutions, announced a 1-for-10 reverse stock split effective May 21, 2026. This action aims to meet the Nasdaq minimum bid price requirement, preserving its listing status. The reverse split will consolidate every 10 shares into one, reducing outstanding shares from approximately 11…

VisionWave Holdings to Stage Private Showcase of Varan Unmanned Ground Vehicle at Eurosatory 2026 in Paris

VisionWave Holdings to Stage Private Showcase of Varan Unmanned Ground Vehicle at Eurosatory 2026 in Paris

VisionWave Holdings is hosting a private showcase at Eurosatory 2026 to debut its Varan Unmanned Ground Vehicle (UGV), an innovative modular autonomous platform designed for diverse defense missions. The event also highlights VisionWave's tactical aerial drone fleet and Foresight 3D Sensing software, enhancing autonomous operations in contested env…

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) Unveils Five-Pillar Digital Infrastructure Holding Company Strategy Across Africa and Asia-Pacific

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) Unveils Five-Pillar Digital Infrastructure Holding Company Strategy Across Africa and Asia-Pacific

Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) announced a strategic evolution into a multi-vertical digital infrastructure holding company focused on sovereign digital identity, cybersecurity, AI systems, digital commerce, and agricultural technology across Africa and Asia-Pacific regions. Building on a prior $800 million Ghana joint venture fr…

Rezolve Ai Solves the 26% AI Distortion Crisis Stalling Global Retail; Peer-Reviewed Research Validates Near-Perfect Accuracy

Rezolve Ai Solves the 26% AI Distortion Crisis Stalling Global Retail; Peer-Reviewed Research Validates Near-Perfect Accuracy

Rezolve Ai announced that peer-reviewed research validates its TraceWare verification technology, demonstrating near-perfect accuracy in preventing AI hallucinations and distortions in commerce transactions. This research reveals that generic AI models currently distort product reviews and have high hallucination rates, undermining reliability in r…